| UniProt ID | EIF3L_HUMAN | |
|---|---|---|
| UniProt AC | Q9Y262 | |
| Protein Name | Eukaryotic translation initiation factor 3 subunit L {ECO:0000255|HAMAP-Rule:MF_03011} | |
| Gene Name | EIF3L {ECO:0000255|HAMAP-Rule:MF_03011} | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 564 | |
| Subcellular Localization | Cytoplasm . | |
| Protein Description | Component of the eukaryotic translation initiation factor 3 (eIF-3) complex, which is required for several steps in the initiation of protein synthesis. [PubMed: 17581632] | |
| Protein Sequence | MSYPADDYESEAAYDPYAYPSDYDMHTGDPKQDLAYERQYEQQTYQVIPEVIKNFIQYFHKTVSDLIDQKVYELQASRVSSDVIDQKVYEIQDIYENSWTKLTERFFKNTPWPEAEAIAPQVGNDAVFLILYKELYYRHIYAKVSGGPSLEQRFESYYNYCNLFNYILNADGPAPLELPNQWLWDIIDEFIYQFQSFSQYRCKTAKKSEEEIDFLRSNPKIWNVHSVLNVLHSLVDKSNINRQLEVYTSGGDPESVAGEYGRHSLYKMLGYFSLVGLLRLHSLLGDYYQAIKVLENIELNKKSMYSRVPECQVTTYYYVGFAYLMMRRYQDAIRVFANILLYIQRTKSMFQRTTYKYEMINKQNEQMHALLAIALTMYPMRIDESIHLQLREKYGDKMLRMQKGDPQVYEELFSYSCPKFLSPVVPNYDNVHPNYHKEPFLQQLKVFSDEVQQQAQLSTIRSFLKLYTTMPVAKLAGFLDLTEQEFRIQLLVFKHKMKNLVWTSGISALDGEFQSASEVDFYIDKDMIHIADTKVARRYGDFFIRQIHKFEELNRTLKKMGQRP | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MSYPADDYE ------CCCCCCCCC | 39.56 | 17322308 | |
| 2 | Phosphorylation | ------MSYPADDYE ------CCCCCCCCC | 39.56 | 23663014 | |
| 3 | Phosphorylation | -----MSYPADDYES -----CCCCCCCCCC | 10.92 | 23663014 | |
| 8 | Phosphorylation | MSYPADDYESEAAYD CCCCCCCCCCCCCCC | 23.15 | 23663014 | |
| 10 | Phosphorylation | YPADDYESEAAYDPY CCCCCCCCCCCCCCC | 26.72 | 23663014 | |
| 14 | Phosphorylation | DYESEAAYDPYAYPS CCCCCCCCCCCCCCC | 25.21 | 26074081 | |
| 17 | Phosphorylation | SEAAYDPYAYPSDYD CCCCCCCCCCCCCCC | 18.83 | 28450419 | |
| 19 | Phosphorylation | AAYDPYAYPSDYDMH CCCCCCCCCCCCCCC | 9.45 | 26074081 | |
| 21 | Phosphorylation | YDPYAYPSDYDMHTG CCCCCCCCCCCCCCC | 35.81 | 26074081 | |
| 23 | Phosphorylation | PYAYPSDYDMHTGDP CCCCCCCCCCCCCCC | 21.36 | 26074081 | |
| 27 | Phosphorylation | PSDYDMHTGDPKQDL CCCCCCCCCCCHHHH | 36.32 | 26074081 | |
| 36 | Phosphorylation | DPKQDLAYERQYEQQ CCHHHHHHHHHHHHH | 20.95 | 21945579 | |
| 40 | Phosphorylation | DLAYERQYEQQTYQV HHHHHHHHHHHHHHH | 23.17 | 21945579 | |
| 44 | Phosphorylation | ERQYEQQTYQVIPEV HHHHHHHHHHHHHHH | 18.67 | 21945579 | |
| 45 | Phosphorylation | RQYEQQTYQVIPEVI HHHHHHHHHHHHHHH | 9.10 | 21945579 | |
| 45 | Ubiquitination | RQYEQQTYQVIPEVI HHHHHHHHHHHHHHH | 9.10 | 21963094 | |
| 58 | Phosphorylation | VIKNFIQYFHKTVSD HHHHHHHHHHHHHHH | 11.66 | 28152594 | |
| 61 | Ubiquitination | NFIQYFHKTVSDLID HHHHHHHHHHHHHHH | 40.50 | - | |
| 62 | Phosphorylation | FIQYFHKTVSDLIDQ HHHHHHHHHHHHHHH | 19.37 | 30622161 | |
| 64 | Phosphorylation | QYFHKTVSDLIDQKV HHHHHHHHHHHHHHH | 31.75 | 21712546 | |
| 70 | Acetylation | VSDLIDQKVYELQAS HHHHHHHHHHHHHHH | 42.93 | 26051181 | |
| 70 | Ubiquitination | VSDLIDQKVYELQAS HHHHHHHHHHHHHHH | 42.93 | 21906983 | |
| 72 | Phosphorylation | DLIDQKVYELQASRV HHHHHHHHHHHHHCC | 20.25 | 28152594 | |
| 77 | Phosphorylation | KVYELQASRVSSDVI HHHHHHHHCCCCHHH | 21.91 | 28152594 | |
| 80 | Phosphorylation | ELQASRVSSDVIDQK HHHHHCCCCHHHCCH | 21.51 | 28985074 | |
| 81 | Phosphorylation | LQASRVSSDVIDQKV HHHHCCCCHHHCCHH | 32.80 | 21712546 | |
| 87 | Ubiquitination | SSDVIDQKVYEIQDI CCHHHCCHHEEHHHH | 42.93 | 21906983 | |
| 89 | Phosphorylation | DVIDQKVYEIQDIYE HHHCCHHEEHHHHHH | 17.85 | 27273156 | |
| 95 | Phosphorylation | VYEIQDIYENSWTKL HEEHHHHHHCCHHHH | 19.83 | 29496907 | |
| 98 | Phosphorylation | IQDIYENSWTKLTER HHHHHHCCHHHHHHH | 24.96 | 30622161 | |
| 100 | Phosphorylation | DIYENSWTKLTERFF HHHHCCHHHHHHHHH | 18.92 | 30622161 | |
| 101 | Ubiquitination | IYENSWTKLTERFFK HHHCCHHHHHHHHHH | 47.34 | 21890473 | |
| 101 | Acetylation | IYENSWTKLTERFFK HHHCCHHHHHHHHHH | 47.34 | 26051181 | |
| 101 | Ubiquitination | IYENSWTKLTERFFK HHHCCHHHHHHHHHH | 47.34 | 21906983 | |
| 109 | Ubiquitination | LTERFFKNTPWPEAE HHHHHHHCCCCHHHH | 46.33 | 24816145 | |
| 110 | Phosphorylation | TERFFKNTPWPEAEA HHHHHHCCCCHHHHH | 27.59 | 28674151 | |
| 113 | Ubiquitination | FFKNTPWPEAEAIAP HHHCCCCHHHHHHCC | 31.93 | 21963094 | |
| 122 | Ubiquitination | AEAIAPQVGNDAVFL HHHHCCCCCCHHHHH | 8.23 | 21963094 | |
| 130 | Ubiquitination | GNDAVFLILYKELYY CCHHHHHHHHHHHHH | 2.41 | 21963094 | |
| 139 | Ubiquitination | YKELYYRHIYAKVSG HHHHHHHHHHHHCCC | 10.99 | 21963094 | |
| 143 | Acetylation | YYRHIYAKVSGGPSL HHHHHHHHCCCCCCH | 21.69 | 26051181 | |
| 143 | Ubiquitination | YYRHIYAKVSGGPSL HHHHHHHHCCCCCCH | 21.69 | 21906983 | |
| 144 | Ubiquitination | YRHIYAKVSGGPSLE HHHHHHHCCCCCCHH | 4.97 | 21963094 | |
| 145 | Phosphorylation | RHIYAKVSGGPSLEQ HHHHHHCCCCCCHHH | 37.01 | 23403867 | |
| 159 | Ubiquitination | QRFESYYNYCNLFNY HHHHHHHHHHHHHHH | 27.01 | 24816145 | |
| 172 | Ubiquitination | NYILNADGPAPLELP HHHHCCCCCCCCCCC | 20.19 | 21963094 | |
| 186 | Ubiquitination | PNQWLWDIIDEFIYQ CCHHHHHHHHHHHHH | 2.64 | 21963094 | |
| 189 | Ubiquitination | WLWDIIDEFIYQFQS HHHHHHHHHHHHHHC | 24.44 | 21963094 | |
| 203 | Ubiquitination | SFSQYRCKTAKKSEE CCCCCCCCCCCCCHH | 42.38 | 22817900 | |
| 204 | Ubiquitination | FSQYRCKTAKKSEEE CCCCCCCCCCCCHHH | 47.54 | 22817900 | |
| 206 | Ubiquitination | QYRCKTAKKSEEEID CCCCCCCCCCHHHHH | 63.16 | - | |
| 207 | 2-Hydroxyisobutyrylation | YRCKTAKKSEEEIDF CCCCCCCCCHHHHHH | 61.71 | - | |
| 207 | Ubiquitination | YRCKTAKKSEEEIDF CCCCCCCCCHHHHHH | 61.71 | 24816145 | |
| 208 | Phosphorylation | RCKTAKKSEEEIDFL CCCCCCCCHHHHHHH | 49.92 | 30622161 | |
| 220 | Ubiquitination | DFLRSNPKIWNVHSV HHHHCCCCHHHHHHH | 65.68 | 21963094 | |
| 226 | Phosphorylation | PKIWNVHSVLNVLHS CCHHHHHHHHHHHHH | 24.82 | 28450419 | |
| 237 | Ubiquitination | VLHSLVDKSNINRQL HHHHHHCCCCCCCEE | 37.61 | 21963094 | |
| 247 | Phosphorylation | INRQLEVYTSGGDPE CCCEEEEEECCCCHH | 5.94 | 20068231 | |
| 249 | Ubiquitination | RQLEVYTSGGDPESV CEEEEEECCCCHHHH | 24.08 | 24816145 | |
| 250 | Ubiquitination | QLEVYTSGGDPESVA EEEEEECCCCHHHHH | 36.40 | 24816145 | |
| 253 | Ubiquitination | VYTSGGDPESVAGEY EEECCCCHHHHHCCC | 38.75 | 22817900 | |
| 254 | Ubiquitination | YTSGGDPESVAGEYG EECCCCHHHHHCCCH | 63.69 | 22817900 | |
| 255 | Phosphorylation | TSGGDPESVAGEYGR ECCCCHHHHHCCCHH | 23.74 | 28152594 | |
| 258 | Ubiquitination | GDPESVAGEYGRHSL CCHHHHHCCCHHHHH | 26.88 | 21963094 | |
| 260 | Phosphorylation | PESVAGEYGRHSLYK HHHHHCCCHHHHHHH | 20.67 | 28152594 | |
| 263 | Ubiquitination | VAGEYGRHSLYKMLG HHCCCHHHHHHHHHH | 20.14 | 21963094 | |
| 264 | Ubiquitination | AGEYGRHSLYKMLGY HCCCHHHHHHHHHHH | 31.84 | 23503661 | |
| 268 | Sulfoxidation | GRHSLYKMLGYFSLV HHHHHHHHHHHHHHH | 1.91 | 28183972 | |
| 280 | Ubiquitination | SLVGLLRLHSLLGDY HHHHHHHHHHHHCHH | 3.03 | 21963094 | |
| 287 | Phosphorylation | LHSLLGDYYQAIKVL HHHHHCHHHHHHHHH | 8.83 | 20090780 | |
| 288 | Phosphorylation | HSLLGDYYQAIKVLE HHHHCHHHHHHHHHH | 9.01 | 20090780 | |
| 299 | Ubiquitination | KVLENIELNKKSMYS HHHHHCCCCCCCHHH | 11.45 | 24816145 | |
| 301 | 2-Hydroxyisobutyrylation | LENIELNKKSMYSRV HHHCCCCCCCHHHCC | 59.87 | - | |
| 301 | Acetylation | LENIELNKKSMYSRV HHHCCCCCCCHHHCC | 59.87 | 23954790 | |
| 301 | Malonylation | LENIELNKKSMYSRV HHHCCCCCCCHHHCC | 59.87 | 26320211 | |
| 301 | Ubiquitination | LENIELNKKSMYSRV HHHCCCCCCCHHHCC | 59.87 | 27667366 | |
| 302 | Ubiquitination | ENIELNKKSMYSRVP HHCCCCCCCHHHCCC | 39.11 | 22817900 | |
| 305 | Ubiquitination | ELNKKSMYSRVPECQ CCCCCCHHHCCCCCE | 10.62 | 30230243 | |
| 308 | Ubiquitination | KKSMYSRVPECQVTT CCCHHHCCCCCEEEE | 3.73 | 21963094 | |
| 314 | Ubiquitination | RVPECQVTTYYYVGF CCCCCEEEEHHHHHH | 5.34 | 23503661 | |
| 321 | Ubiquitination | TTYYYVGFAYLMMRR EEHHHHHHHHHHHHH | 2.63 | 21890473 | |
| 339 | Ubiquitination | AIRVFANILLYIQRT HHHHHHHHHHHHHHH | 2.22 | 22817900 | |
| 342 | Phosphorylation | VFANILLYIQRTKSM HHHHHHHHHHHHHHH | 7.49 | - | |
| 344 | Ubiquitination | ANILLYIQRTKSMFQ HHHHHHHHHHHHHHH | 33.17 | 22817900 | |
| 345 | Ubiquitination | NILLYIQRTKSMFQR HHHHHHHHHHHHHHH | 34.26 | 22817900 | |
| 347 | 2-Hydroxyisobutyrylation | LLYIQRTKSMFQRTT HHHHHHHHHHHHHHH | 41.95 | - | |
| 347 | Acetylation | LLYIQRTKSMFQRTT HHHHHHHHHHHHHHH | 41.95 | 27452117 | |
| 347 | Ubiquitination | LLYIQRTKSMFQRTT HHHHHHHHHHHHHHH | 41.95 | 24816145 | |
| 349 | Ubiquitination | YIQRTKSMFQRTTYK HHHHHHHHHHHHHHH | 3.37 | 24816145 | |
| 355 | Phosphorylation | SMFQRTTYKYEMINK HHHHHHHHHHHHCCC | 15.80 | 29496907 | |
| 355 | Ubiquitination | SMFQRTTYKYEMINK HHHHHHHHHHHHCCC | 15.80 | 32015554 | |
| 356 | 2-Hydroxyisobutyrylation | MFQRTTYKYEMINKQ HHHHHHHHHHHCCCH | 32.42 | - | |
| 356 | Acetylation | MFQRTTYKYEMINKQ HHHHHHHHHHHCCCH | 32.42 | 26051181 | |
| 356 | Ubiquitination | MFQRTTYKYEMINKQ HHHHHHHHHHHCCCH | 32.42 | 21906983 | |
| 357 | Phosphorylation | FQRTTYKYEMINKQN HHHHHHHHHHCCCHH | 10.58 | 20090780 | |
| 362 | Ubiquitination | YKYEMINKQNEQMHA HHHHHCCCHHHHHHH | 43.50 | 23503661 | |
| 367 | Ubiquitination | INKQNEQMHALLAIA CCCHHHHHHHHHHHH | 1.30 | 21963094 | |
| 371 | Ubiquitination | NEQMHALLAIALTMY HHHHHHHHHHHHHHC | 3.17 | 21890473 | |
| 376 | Phosphorylation | ALLAIALTMYPMRID HHHHHHHHHCCCCCC | 12.97 | 27251275 | |
| 385 | Phosphorylation | YPMRIDESIHLQLRE CCCCCCCHHHHHHHH | 16.15 | 27251275 | |
| 386 | Ubiquitination | PMRIDESIHLQLREK CCCCCCHHHHHHHHH | 3.37 | 21890473 | |
| 389 | Acetylation | IDESIHLQLREKYGD CCCHHHHHHHHHHHH | 25.06 | 19608861 | |
| 389 | Ubiquitination | IDESIHLQLREKYGD CCCHHHHHHHHHHHH | 25.06 | 22817900 | |
| 390 | Ubiquitination | DESIHLQLREKYGDK CCHHHHHHHHHHHHH | 10.85 | 24816145 | |
| 393 | Ubiquitination | IHLQLREKYGDKMLR HHHHHHHHHHHHHHH | 48.37 | - | |
| 394 | Phosphorylation | HLQLREKYGDKMLRM HHHHHHHHHHHHHHH | 26.29 | - | |
| 396 | Ubiquitination | QLREKYGDKMLRMQK HHHHHHHHHHHHHCC | 30.06 | 21890473 | |
| 397 | 2-Hydroxyisobutyrylation | LREKYGDKMLRMQKG HHHHHHHHHHHHCCC | 35.16 | - | |
| 397 | Acetylation | LREKYGDKMLRMQKG HHHHHHHHHHHHCCC | 35.16 | 25953088 | |
| 397 | Malonylation | LREKYGDKMLRMQKG HHHHHHHHHHHHCCC | 35.16 | 26320211 | |
| 397 | Ubiquitination | LREKYGDKMLRMQKG HHHHHHHHHHHHCCC | 35.16 | 24816145 | |
| 398 | Ubiquitination | REKYGDKMLRMQKGD HHHHHHHHHHHCCCC | 3.23 | 23503661 | |
| 399 | Ubiquitination | EKYGDKMLRMQKGDP HHHHHHHHHHCCCCH | 5.20 | 21963094 | |
| 400 | Ubiquitination | KYGDKMLRMQKGDPQ HHHHHHHHHCCCCHH | 23.22 | 23503661 | |
| 403 | Acetylation | DKMLRMQKGDPQVYE HHHHHHCCCCHHHHH | 56.81 | 26051181 | |
| 403 | Malonylation | DKMLRMQKGDPQVYE HHHHHHCCCCHHHHH | 56.81 | 26320211 | |
| 403 | Ubiquitination | DKMLRMQKGDPQVYE HHHHHHCCCCHHHHH | 56.81 | 32015554 | |
| 404 | Ubiquitination | KMLRMQKGDPQVYEE HHHHHCCCCHHHHHH | 34.63 | 21890473 | |
| 405 | Ubiquitination | MLRMQKGDPQVYEEL HHHHCCCCHHHHHHH | 37.18 | 23503661 | |
| 409 | Phosphorylation | QKGDPQVYEELFSYS CCCCHHHHHHHHCCC | 9.84 | 29759185 | |
| 414 | Phosphorylation | QVYEELFSYSCPKFL HHHHHHHCCCCHHHH | 28.85 | 28152594 | |
| 415 | Phosphorylation | VYEELFSYSCPKFLS HHHHHHCCCCHHHHC | 13.63 | 20090780 | |
| 416 | Phosphorylation | YEELFSYSCPKFLSP HHHHHCCCCHHHHCC | 23.81 | 28152594 | |
| 417 | Acetylation | EELFSYSCPKFLSPV HHHHCCCCHHHHCCC | 3.01 | 19608861 | |
| 417 | Glutathionylation | EELFSYSCPKFLSPV HHHHCCCCHHHHCCC | 3.01 | 22555962 | |
| 417 | S-palmitoylation | EELFSYSCPKFLSPV HHHHCCCCHHHHCCC | 3.01 | 29575903 | |
| 417 | Ubiquitination | EELFSYSCPKFLSPV HHHHCCCCHHHHCCC | 3.01 | 27667366 | |
| 419 | Acetylation | LFSYSCPKFLSPVVP HHCCCCHHHHCCCCC | 64.36 | 25953088 | |
| 419 | Ubiquitination | LFSYSCPKFLSPVVP HHCCCCHHHHCCCCC | 64.36 | 21906983 | |
| 422 | Phosphorylation | YSCPKFLSPVVPNYD CCCHHHHCCCCCCCC | 20.84 | 25159151 | |
| 428 | Phosphorylation | LSPVVPNYDNVHPNY HCCCCCCCCCCCCCC | 11.65 | 29496907 | |
| 434 | Ubiquitination | NYDNVHPNYHKEPFL CCCCCCCCCCCCHHH | 36.34 | 24816145 | |
| 435 | Phosphorylation | YDNVHPNYHKEPFLQ CCCCCCCCCCCHHHH | 20.79 | 29496907 | |
| 436 | Ubiquitination | DNVHPNYHKEPFLQQ CCCCCCCCCCHHHHH | 34.34 | 27667366 | |
| 437 | Acetylation | NVHPNYHKEPFLQQL CCCCCCCCCHHHHHH | 57.64 | 23954790 | |
| 437 | Malonylation | NVHPNYHKEPFLQQL CCCCCCCCCHHHHHH | 57.64 | 26320211 | |
| 437 | Ubiquitination | NVHPNYHKEPFLQQL CCCCCCCCCHHHHHH | 57.64 | 22817900 | |
| 440 | Ubiquitination | PNYHKEPFLQQLKVF CCCCCCHHHHHHHHC | 11.45 | 24816145 | |
| 445 | Acetylation | EPFLQQLKVFSDEVQ CHHHHHHHHCCHHHH | 36.57 | 8273333 | |
| 445 | Ubiquitination | EPFLQQLKVFSDEVQ CHHHHHHHHCCHHHH | 36.57 | - | |
| 446 | Ubiquitination | PFLQQLKVFSDEVQQ HHHHHHHHCCHHHHH | 8.26 | 21890473 | |
| 448 | Ubiquitination | LQQLKVFSDEVQQQA HHHHHHCCHHHHHHH | 35.53 | 23503661 | |
| 450 | Ubiquitination | QLKVFSDEVQQQAQL HHHHCCHHHHHHHHH | 40.82 | 23503661 | |
| 451 | Ubiquitination | LKVFSDEVQQQAQLS HHHCCHHHHHHHHHH | 8.16 | 33845483 | |
| 458 | Phosphorylation | VQQQAQLSTIRSFLK HHHHHHHHHHHHHHH | 15.09 | 30622161 | |
| 459 | Phosphorylation | QQQAQLSTIRSFLKL HHHHHHHHHHHHHHH | 29.06 | 30622161 | |
| 461 | Ubiquitination | QAQLSTIRSFLKLYT HHHHHHHHHHHHHHH | 22.80 | 21890473 | |
| 461 | Ubiquitination | QAQLSTIRSFLKLYT HHHHHHHHHHHHHHH | 22.80 | 24816145 | |
| 462 | Phosphorylation | AQLSTIRSFLKLYTT HHHHHHHHHHHHHHH | 30.95 | 24719451 | |
| 462 | Ubiquitination | AQLSTIRSFLKLYTT HHHHHHHHHHHHHHH | 30.95 | 21890473 | |
| 465 | Acetylation | STIRSFLKLYTTMPV HHHHHHHHHHHHHCH | 37.12 | 19608861 | |
| 465 | Ubiquitination | STIRSFLKLYTTMPV HHHHHHHHHHHHHCH | 37.12 | 21906983 | |
| 470 | Sulfoxidation | FLKLYTTMPVAKLAG HHHHHHHHCHHHHHC | 1.61 | 30846556 | |
| 474 | Ubiquitination | YTTMPVAKLAGFLDL HHHHCHHHHHCCCCC | 38.82 | - | |
| 480 | Ubiquitination | AKLAGFLDLTEQEFR HHHHCCCCCCCCHHH | 49.65 | 21890473 | |
| 486 | Ubiquitination | LDLTEQEFRIQLLVF CCCCCCHHHHHHHHH | 9.24 | 27667366 | |
| 494 | Acetylation | RIQLLVFKHKMKNLV HHHHHHHHHHCCCCC | 34.53 | 26051181 | |
| 494 | Ubiquitination | RIQLLVFKHKMKNLV HHHHHHHHHHCCCCC | 34.53 | 21890473 | |
| 496 | Ubiquitination | QLLVFKHKMKNLVWT HHHHHHHHCCCCCCC | 52.76 | 23503661 | |
| 498 | Ubiquitination | LVFKHKMKNLVWTSG HHHHHHCCCCCCCCC | 52.51 | 23503661 | |
| 501 | Acetylation | KHKMKNLVWTSGISA HHHCCCCCCCCCHHH | 7.97 | 19608861 | |
| 501 | Ubiquitination | KHKMKNLVWTSGISA HHHCCCCCCCCCHHH | 7.97 | 33845483 | |
| 508 | Ubiquitination | VWTSGISALDGEFQS CCCCCHHHCCCCCCC | 14.04 | 21963094 | |
| 511 | Ubiquitination | SGISALDGEFQSASE CCHHHCCCCCCCHHE | 38.17 | 24816145 | |
| 534 | 2-Hydroxyisobutyrylation | MIHIADTKVARRYGD HEEECCHHHHHHHHH | 34.15 | - | |
| 534 | Ubiquitination | MIHIADTKVARRYGD HEEECCHHHHHHHHH | 34.15 | 21906983 | |
| 537 | Ubiquitination | IADTKVARRYGDFFI ECCHHHHHHHHHHHH | 35.03 | 21890473 | |
| 539 | Phosphorylation | DTKVARRYGDFFIRQ CHHHHHHHHHHHHHH | 18.59 | 28152594 | |
| 539 | Ubiquitination | DTKVARRYGDFFIRQ CHHHHHHHHHHHHHH | 18.59 | 23503661 | |
| 541 | Ubiquitination | KVARRYGDFFIRQIH HHHHHHHHHHHHHHH | 26.75 | 23503661 | |
| 549 | Acetylation | FFIRQIHKFEELNRT HHHHHHHHHHHHHHH | 56.98 | 19608861 | |
| 549 | Malonylation | FFIRQIHKFEELNRT HHHHHHHHHHHHHHH | 56.98 | 26320211 | |
| 549 | Ubiquitination | FFIRQIHKFEELNRT HHHHHHHHHHHHHHH | 56.98 | 33845483 | |
| 556 | Phosphorylation | KFEELNRTLKKMGQR HHHHHHHHHHHHCCC | 41.68 | 23186163 | |
| 558 | Methylation | EELNRTLKKMGQRP- HHHHHHHHHHCCCC- | 39.85 | - | |
| 559 | Ubiquitination | ELNRTLKKMGQRP-- HHHHHHHHHCCCC-- | 51.91 | 24816145 | |
| 575 | Ubiquitination | ------------------ ------------------ | 24816145 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of EIF3L_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of EIF3L_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of EIF3L_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Structural characterization of the human eukaryotic initiation factor3 protein complex by mass spectrometry."; Damoc E., Fraser C.S., Zhou M., Videler H., Mayeur G.L.,Hershey J.W.B., Doudna J.A., Robinson C.V., Leary J.A.; Mol. Cell. Proteomics 6:1135-1146(2007). Cited for: IDENTIFICATION IN THE EIF-3 COMPLEX, CHARACTERIZATION OF THE EIF-3COMPLEX, CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT SER-2, ANDMASS SPECTROMETRY. | |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-437; LYS-465 AND LYS-549,AND MASS SPECTROMETRY. | |